Actinium pharmaceuticals, inc. (ATNM)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenue

-

-

-

-

0

0

0

0

0

0

Operating expenses:
Research and development, net of reimbursements

16,549

17,094

17,719

17,828

13,501

12,267

3,109

3,440

323

-

General and administrative

5,521

6,732

9,190

9,019

11,274

10,175

3,476

4,506

2,959

-

Depreciation expense

-

-

-

-

53

37

1

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

0

0

-

Loss on disposition of equipment

-

-

-

-

-

-

-4

0

-

-

Loss on disposition of equipment

-

-

-

-

-

-

-

-

0

-

Cost of Goods

-

-

-

-

-

-

-

-

-

0

Gross profit

-

-

-

-

-

-

-

-

-

0

Bank charges (Expenses)

-

-

-

-

-

-

-

-

-

0

Other costs

-

-

-

-

-

-

-

-

-

0

Professional fees

-

-

-

-

-

-

-

-

-

25

Total operating expenses

22,071

23,827

26,910

26,847

24,829

22,480

6,591

7,947

3,283

26

Loss from operations

-22,071

-23,827

-26,910

-26,847

-24,829

-22,480

-6,591

-7,947

-3,283

-26

Other income:
Interest income - net

172

173

5

-5

-

-

-

-

-

-

Interest income

-

-

-

-

-7

-

-

-

-

-

Gain on retention of deposit

-

-

-

-

-

-

-

-

-

35

Interest expense

-

-

-

-

-

0

2

1,099

-175

-6

Gain on extinguishment of liability

-

-

-

-

-

-

-

0

0

-

Gain on change in fair value of derivative liabilities

-

-

304

2,530

3,812

-2,206

-4,179

685

-13

-

State corporate tax expense

-

-

-

-

-

-

-

-

-

-0

Total other income

172

173

309

2,525

3,804

-2,206

-4,181

-413

161

27

Net loss

-21,899

-23,653

-26,601

-24,321

-21,025

-24,687

-10,773

-8,361

-3,444

-

Deemed dividend for warrant down-round protection provision

1

-

-

-

-

-

-

-

-

-

Net loss applicable to common stockholders

-21,900

-23,653

-

-

-

-

-

-

-

-

Net income (loss)

-

-

-

-

-

-

-

-

-

1

Loss per common share - basic and diluted

-0.15

-0.22

-0.40

-0.50

-0.55

-0.90

-0.47

-7.58

-4.30

0.01

Weighted average common shares outstanding - basic and diluted

149,271

106,041

66,746

48,463

38,158

27,363

22,752

1,103

801

-

Weighted average of shares outstanding

-

-

-

-

-

-

-

-

-

11,155